Literature DB >> 2728851

The role of life events in the myasthenia gravis outcome: a one-year longitudinal study.

G Magni1, G Micaglio, M B Ceccato, R Lalli, L Bejato, C Angelini.   

Abstract

We examined 51 patients suffering from myasthenia gravis (MG) and studied the relevance of stressful life events in relation to the course of the disease. Life events were assessed by means of the Paykel's Interview for Recent Life Events. The stage severity of MG was assessed by means of the Osserman and Genkins scale, twice per patient, at one year intervals. Simultaneously, life events were assessed for the 12 months preceding each of the 2 assessments of MG. Over the 2 MG evaluations 16 patients improved, 6 worsened and in 29 no change took place. Using life events data collected at the first interview, and applying a prospective design, no difference was found between patients who improved and those who remained unchanged or worsened. Life events reported at the second interview, as having occurred during the inter-assessment year, and collected according to a retrospective design, were significantly fewer in improvers than in non-improvers.

Entities:  

Mesh:

Year:  1989        PMID: 2728851     DOI: 10.1111/j.1600-0404.1989.tb03786.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  The Relationship of Symptoms of Anxiety and Depression with Disease Severity and Treatment Modality in Myasthenia Gravis: A Cross-sectional Study.

Authors:  Fikret Aysal; Oğuz Karamustafalioğlu; Başak Özçelik; Meltem Yilmaz; Nesrin Karamustafalioğlu; Hüseyin Yumrukçal; Onur Tankaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

2.  Myasthenia Gravis.

Authors:  Michael Graves; Jonathan S. Katz
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.598

Review 3.  Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.

Authors:  Isin Baral Kulaksizoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.

Authors:  Giulio Sansone; Domenico Marco Bonifati
Journal:  J Neurol       Date:  2022-05-03       Impact factor: 6.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.